A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy

[1]  Z. Liao,et al.  Survival Patterns for Patients with Resected N2 Non–Small Cell Lung Cancer and Postoperative Radiotherapy: A Prognostic Scoring Model and Heat Map Approach , 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  Haiquan Chen,et al.  Upfront surgery as first‐line therapy in selected patients with stage IIIA non–small cell lung cancer , 2017, The Journal of thoracic and cardiovascular surgery.

[4]  M. Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Steven H. Lin,et al.  A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Haiquan Chen,et al.  The prognostic value of lymph node ratio and log odds of positive lymph nodes in patients with lung adenocarcinoma , 2017, The Journal of thoracic and cardiovascular surgery.

[7]  Yang Zhang,et al.  Precise Diagnosis of Intraoperative Frozen Section Is an Effective Method to Guide Resection Strategy for Peripheral Small-Sized Lung Adenocarcinoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer , 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  David R. Jones,et al.  Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer. , 2013, The Annals of thoracic surgery.

[10]  D. de Ruysscher,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  B. Solomon,et al.  Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  W. Dong,et al.  The Prognostic Value of Ratio-Based Lymph Node Staging in Resected Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[13]  Austin Miller,et al.  Number of lymph nodes and metastatic lymph node ratio are associated with survival in lung cancer. , 2012, The Annals of thoracic surgery.

[14]  S. Burdett,et al.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. , 2010 .

[15]  V. Wong,et al.  Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  V. Rusch,et al.  The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  S. Keleş,et al.  Residual‐based tree‐structured survival analysis , 2002, Statistics in medicine.